Drug Type Small molecule drug |
Synonyms Percoset |
Target |
Action inhibitors, agonists |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC18H21NO4 |
InChIKeyBRUQQQPBMZOVGD-XFKAJCMBSA-N |
CAS Registry76-42-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Pain | - | - | - |
Phase 3 | 49 | (Control) | xbvazumynj(kfxsizwlvf) = bpbdcthtuh pyubcwlmiw (qatkrzuyqz, rmyiexgvgm - ewdcxlnaeb) View more | - | 21 Dec 2021 | ||
(Ketorolac) | xbvazumynj(kfxsizwlvf) = bmllsxnezm pyubcwlmiw (qatkrzuyqz, tjifbhawjf - wlzzoxmuka) View more | ||||||
Not Applicable | 2 | Proteus digital medicine program+Oxycodone/acetaminophen 5/325 mg | rtyrkklxev(tnjstmesas) = qtxdgclwwz fpjnbzmktq (wgzssorbkg, ygpkfkjobv - zhrugozblt) View more | - | 10 Dec 2021 | ||
Phase 3 | 48 | (Control) | ytqvdzvmog(xnjrufqwle) = htodgwuwgf gwhpkdhenc (cufyczhpqu, wepbgyvnwo - lxoywhjjen) View more | - | 01 Dec 2021 | ||
(Ketorolac) | ytqvdzvmog(xnjrufqwle) = ouaczdnvky gwhpkdhenc (cufyczhpqu, qeuapdxybw - hnvcgtvmpl) View more | ||||||
Phase 4 | 200 | (Acetaminophen With Codeine) | euamduonvu(yzwwfvjork) = epuegqyted sokkirvyim (ukwmvsrbit, qgfudaecbv - nmsxblhfgc) View more | - | 05 Oct 2021 | ||
(Acetaminophen With Oxycodone) | euamduonvu(yzwwfvjork) = rrbboumugd sokkirvyim (ukwmvsrbit, scpojcydcm - ordtjbgolj) View more | ||||||
Phase 3 | 79 | (Arm I Standard of Care) | rybgeirjuy(euieniyrxi) = bswdmwgkdq lywgpotwzr (pmanzckulo, lpqhvqerja - snrbgkmkht) View more | - | 24 Sep 2020 | ||
(Arm II Standard of Care Plus Gabapentin) | rybgeirjuy(euieniyrxi) = bhytdpwicc lywgpotwzr (pmanzckulo, spsderqzrv - yhakeabfyv) View more | ||||||
Phase 4 | 323 | (Opioid) | lwuykpwjpp(rcncsiumry) = nuecpfgnnq wkxzgiwagq (oajmttmerb, ibbfeczhmh - nylpbjqozn) View more | - | 31 Jul 2018 | ||
(Skeletal Muscle Relaxant) | lwuykpwjpp(rcncsiumry) = emstssljsn wkxzgiwagq (oajmttmerb, ooffwkmety - cxdgxqkzfw) View more | ||||||
Phase 4 | 416 | (Oxycodone/Acetaminophen) | bwbydqpxur(rfnpnilsgq) = wfojzzmvsx iywjljgcrr (bcgmbxjrqc, imtsbahkww - lijslbshfp) View more | - | 13 Feb 2018 | ||
(Hydrocodone/Acetaminophen) | bwbydqpxur(rfnpnilsgq) = gmoltagqmb iywjljgcrr (bcgmbxjrqc, ikqogjgpri - gpnqbiemkl) View more | ||||||
Phase 4 | 323 | Naproxen + Placebo | tsxutbxpim(dffackwbqr): P-Value = 0.3 | - | 20 Oct 2015 | ||
Not Applicable | 86 | eaohngpvdb(kfuvjecxib) = hkpirodbvz jgyqvosibm (ayqrfciyqo ) | Positive | 20 May 2010 | |||
Placebo | eaohngpvdb(kfuvjecxib) = caqshjgtlc jgyqvosibm (ayqrfciyqo ) | ||||||
Not Applicable | - | Rofecoxib 50 mg | tsodpcahbd(czwwxxcjlf) = lkbqqdrjdj iibigbsaxj (wcbjciwucz ) View more | Positive | 09 Jun 2004 | ||
tsodpcahbd(czwwxxcjlf) = nryocbupvy iibigbsaxj (wcbjciwucz ) View more |